LINC00926

Across TCGA pan-cancer cohorts, LINC00926 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated LINC00926 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC00926 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC00926 expression acts as an unfavorable survival marker, although some lineages such as HNSC and BLCA show a favorable association.

HNSC, KIRC, and BLCA are the cancer types where LINC00926 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	II,III,IV	0.504	0.247	<.001	132	view →
KIRC	DFS	Median	All	0.545	0.702	<.001	123	view →
BLCA	OS	Quartile	II,III,IV	0.816	0.620	.001	69	view →
BRCA	OS	Median	All	0.605	0.539	<.001	68	view →
LUAD	OS	Tertile	All	0.859	0.736	<.001	57	view →
READ	OS	Quartile	II,III,IV	0.782	0.389	.002	51	view →
LGG	DFS	Median	All	0.288	0.477	<.001	49	view →
OV	DFS	Median	III,IV	0.483	0.577	.003	42	view →
UVM	OS	Median	III,IV	0.304	1.000	.008	28	view →
UCS	DFS	Median	IV	0.952	0.367	.001	24	view →
UCEC	OS	Median	III,IV	0.888	0.759	.007	24	view →
PRAD	DFS	Tertile	All	0.825	0.959	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

LINC00926–HNSC (OS)

Open the HNSC breakdown →